Riskpilot← Back to searchSign inGet full accessZYMENEX HOLDING ApS
APSIn liquidationCVR 21002348Langelinie Allé 35Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100Est. 1998— employees
Revenue 2019
DKK 0
EBITDA margin
—
-2012757% vs 2018
Equity ratio
99.7%
Financial strength
Net profit 2019
DKK -729K
-134% vs 2018
| Revenue | DKK 0 | — |
| EBITDA | DKK -1,4M | -2012757% |
| Net profit | DKK -729K | -134% |
| Total assets | DKK 164,6M | +0% |
| Equity | DKK 164,2M | +1% |
| Employees | — | — |
Legal name
ZYMENEX HOLDING ApS
CVR number
21002348
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
3. juni 1998
Share capital
DKK 157.000.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Langelinie Allé 35
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | 209 | 451 | 1.377 | 0 |
| Staff expenses | -11.698 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -49.570 | -151 | 0 | -0 | 0 | 0 | -0 | -1.409 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -49.570 | -151 | 0 | -0 | 0 | 0 | -0 | -1.409 |
| Net financials | -1.489 | 1.079 | 4.658 | 3.549 | 2.951 | 14.419 | 2.673 | 953 |
| Profit before tax | -51.059 | 928 | 4.658 | 3.549 | 2.951 | 14.419 | 2.673 | -456 |
| Tax | 65 | 232 | 879 | 834 | 651 | 644 | 535 | 273 |
| Net profit | -51.124 | 696 | 3.778 | 2.715 | 2.300 | 13.776 | 2.138 | -729 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 12.857 | 336.925 | 340.407 | 313.357 | 311.721 | 172.754 | 164.319 | 164.607 |
| Equity | -798 | 303.694 | 338.721 | 311.661 | 305.061 | 170.838 | 162.770 | 164.171 |
| Long-term debt | 6.346 | 31.649 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7.309 | 1.583 | 1.686 | 1.696 | 6.659 | 1.917 | 1.550 | 436 |
| Total debt | 13.655 | 33.232 | 1.686 | 1.696 | 6.659 | 1.917 | 1.550 | 436 |
EBITDA margin
-140900000.0%
This company
15.8%
Market median
-891772252% vs market
20122019
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20122019
Return on equity
-0.4%
This company
18.4%
Market median
-102% vs market
20122019
Net profit margin
-72900000.0%
This company
8.1%
Market median
-900000100% vs market
20122019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122019
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20122019
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NT Management | Management | 2019 | — | — |
PP Management | Management | 2015 | — | — |
| Founder | 1998 | — | — | |
PG Management | Management | 1998 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2004 | — | — | |
| Chairman | 2015 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2006 | — | — | |
| Chairman | 2019 | — | — | |
| Chairman | 2005 | — | — | |
| Chairman | 2007 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 1998 | — | — | |
| Chairman | 2004 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2000 | — | — | |
| Chairman | 2010 | — | — | |
| Chairman | 2004 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 1998 | — | — | |
| Board of Directors | 2006 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ZYMENEX HOLDING ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nina Teerés Herne | Management | 0 companies |
| Paolo Patri | Management | 0 companies |
| Bankforeningens Erhvervsudviklingsforening BankInvest Biomedicinsk Udvikling | Founder | 0 companies |
| Pär Gellerfors | Management | 0 companies |
| Ron Cohen | Board of Directors | 0 companies |
| Jens Morten Fogh | Chairman | 0 companies |
| Christian Frank Scheuer | Board of Directors | 0 companies |
| Natallia Misuna | Board of Directors | 0 companies |
| Per Toft Valstorp | Board of Directors | 0 companies |
| Mark Parry-Billings | Chairman | 0 companies |
| Jan Honoré | Chairman | 0 companies |
| Thomas Tscherning | Chairman | 0 companies |
| Paolo Patri | Board of Directors | 0 companies |
| Ola Vestin | Board of Directors | 0 companies |
| Jesper Zeuthen | Chairman | 0 companies |
| Andrew Philip Dickinson | Chairman | 0 companies |
| Claes Magnus Andersson | Board of Directors | 0 companies |
| Claus Juan Møller-San Pedro | Board of Directors | 0 companies |
| Sten Verland | Chairman | 0 companies |
| Fredric David Price | Chairman | 0 companies |
| Danilo Piroli | Board of Directors | 0 companies |
| Martin Bitsch | Board of Directors | 0 companies |
| Bo Jesper Hansen | Board of Directors | 0 companies |